Supplementary Figure 2 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer | Synapse
February 8, 2024Open Access
Supplementary Figure 2 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Tumor growth curves for tumors with varying MHC-I loss